Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
nature of this project, please contact Prof. Tony McNally (T.McNally@warwick.ac.uk ) directly for further information. Essential and Desirable Criteria: 1 or 2.1 degree in chemistry, chemical engineering
-
) (subject to personal qualifications employees are remunerated according to salary group E 13 TV-L) starting October 1, 2025. The position is limited until June 30, 2029. The period of employment is governed
-
is working to be the state’s world-class cancer research institute, jointly resourced by the Federal Department of Health, CALHN and the University of Adelaide. Reporting to Associate Prof. Robin Hobbs
-
well as the irradiation facilities provide unique possibilities for the scientific and industrial use of neutron beams. For a scientific project for Spin-Selective Neutron Detection using Quantum Sensing, we are looking
-
of the research group on “Aggressive Lymphomas” led by Prof. Dr. Georg Lenz in the Department of Medicine A. We offer an excellent research infrastructure with access to state-of-the-art equipment, a
-
ADTKD diagnostics and clinical trials. What you’ll do You will work at the interface of laboratory and data science, and clinical genetics. You will: Establish and characterise the UK ADTKD-MUC1 cohort
-
. The period of employment is governed by the Fixed Term Research Contracts Act (Wissenschaftszeitvertragsgesetz - WissZeitVG). The positions aim at obtaining further academic qualification (usually PhD
-
: implementation science or qualitative research diabetes foot disease research and/or clinical practice. How to apply The first step is to email Associate Professor Peter Lazzarini detailing your academic and
-
, C++, R) Well-developed collaborative skills We offer: The successful candidates will be hosted in the Department og Microbiome Dynamics of Prof. Gianni Panagiotou of the Leibniz-HKI in
-
interdisciplinary, and together we contribute to science and society. Your role You will join the recently established Chemical and Molecular Neurobiology group led by Associate Prof. Ivana Nikić-Spiegel at the LCSB